Taly Dvorkis | Fieldfisher
Skip to main content
Professional background

Professional background

Prior to joining Fieldfisher I spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets.

I specialise in regulatory compliance and assist medical device, biotech and pharmaceutical companies as well as food & beverage companies meet their UK and EU regulatory obligations. I work with companies preparing regulatory submissions and liaising with regulators to assure compliance and market readiness.   

I also have vast commercial and IP experience and spent many years litigating before the UK, EU, and US courts. I am dual-qualified as a NY lawyer and a Solicitor of England & Wales, and also hold Higher Rights of Audience (Solicitor Advocate). 

I have a technical background, having obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. I hold post-graduate diplomas from Oxford (IP Law) as well as King's College (EU Competition Law).

Awards & recognition

Awards & recognition

Client
It is an absolute pleasure working with Taly.  Her professionalism and knowledge are unshakeable, but the quality in which she most shines is the practicality she brings to often complex situations.

Authored pieces

All Resources
A healthcare professional wearing a shirt and tie, with a stethoscope around their neck, uses a tablet device. The background is blurred, showing another person in what appears to be a medical setting.
Public & Regulatory
Insight

Great Britain's new post-market surveillance requirements, six months on

13.01.2026
In June 2025, the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 came into force, bringing new requirements for how manufacturers must conduct and report on post-market surveillance (PMS) in Great Britain. [1]
Learn more
A digital illustration of a glowing DNA double helix strand made up of colorful light particles, set against a dark background with purple and blue hues.
Public & Regulatory
Insight

Looking ahead: Insights for the Life Science and Healthcare Sectors

13.01.2026
Learn more
medical_tablet_device
Public & Regulatory
Insight

Preparing for new pre-market requirements in Great Britain: what MedTech companies need to know

13.01.2026
Learn more
Several packs of pills in various shapes and colors are scattered on a surface. The medication is contained in blister packs, with some capsules being half white and half blue, others in different color combinations. The image uses blue and pink lighting.
Public & Regulatory
Insight

What the UK's clinical trial reforms mean for the pharmaceutical industry

13.01.2026
Learn more
Public & Regulatory
Insight

Stewardship in practice: building a compliant and sustainable medical device lifecycle strategy

13.01.2026
The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not set out in a single UK regulation, MHRA’s post-market surveillance requirements, the Department of Health and Social Care's Design for Life Roadmap, and the NHS Net Zero Supplier Roadmap collectively emphasise clearer lifetime definition, stronger performance monitoring and more sustainable end-of-life planning. 
Learn more

What others say…

Client
It is an absolute pleasure working with Taly.  Her professionalism and knowledge are unshakeable, but the quality in which she most shines is the practicality she brings to often complex situations.